Timothy Eley
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection(2014)1,191 cited
- → Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1(2012)607 cited
- → Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection(2014)538 cited
- → Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options(2012)235 cited
- → Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection(2013)199 cited
- → Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders(2013)138 cited
- → Resistance Analysis of Hepatitis C Virus Genotype 1 Prior Treatment Null Responders Receiving Daclatasvir And Asunaprevir(2013)121 cited
- → Phase I Study of the Effect of Gastric Acid pH Modulators on the Bioavailability of Oral Dasatinib in Healthy Subjects(2009)103 cited
- → 1422 POTENT VIRAL SUPPRESSION WITH ALL-ORAL COMBINATION OF DACLATASVIR (NS5A INHIBITOR) AND GS-7977 (NS5B INHIBITOR), +/− RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GT1, 2, OR 3(2012)80 cited
- → 1356 QUADRUPLE THERAPY WITH BMS-790052, BMS-650032 AND PEG-IFN/RBV FOR 24 WEEKS RESULTS IN 100% SVR12 IN HCV GENOTYPE 1 NULL RESPONDERS(2011)65 cited